{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:31:32Z","timestamp":1792859492296,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"crossref","award":["cstc2021jcyj-msxmX0320"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0320"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.82104469"],"award-info":[{"award-number":["NO.82104469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 82274164"],"award-info":[{"award-number":["NO. 82274164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chongqing traditional Chinese Medicine inheritance and Innovation team project","award":["2023090006KJZX2022WJW008"],"award-info":[{"award-number":["2023090006KJZX2022WJW008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04890-2","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:30:21Z","timestamp":1745422221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["6-Gingerol, an active compound of ginger, attenuates NASH-HCC progression by reprogramming tumor-associated macrophage via the NOX2\/Src\/MAPK signaling pathway"],"prefix":"10.1186","volume":"25","author":[{"given":"Qiurui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"4890_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: a cancer journal for clinicians. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"4890_CR2","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"issue":"7854","key":"4890_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, N\u00fa\u00f1ez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592(7854):450\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03362-0.","journal-title":"Nature"},{"issue":"3","key":"4890_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/hep.0000000000000591","volume":"79","author":"M Li","year":"2024","unstructured":"Li M, Wang L, Cong L, Wong CC, Zhang X, Chen H, et al. Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Hepatology (Baltimore, MD). 2024;79(3):560\u201374. https:\/\/doi.org\/10.1097\/hep.0000000000000591.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"9","key":"4890_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","volume":"34","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen Z, Kuang H, Liu T, Zhu J, Zhou L, et al. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metab. 2022;34(9):1359-76.e7. https:\/\/doi.org\/10.1016\/j.cmet.2022.07.010.","journal-title":"Cell Metab"},{"issue":"1","key":"4890_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6(1):75. https:\/\/doi.org\/10.1038\/s41392-021-00484-9.","journal-title":"Signal Transduct Target Ther"},{"key":"4890_CR7","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-Associated Macrophages in Tumor Immunity. Front Immunol. 2020;11:583084. https:\/\/doi.org\/10.3389\/fimmu.2020.583084.","journal-title":"Front Immunol"},{"key":"4890_CR8","doi-asserted-by":"publisher","unstructured":"Yang Y, Sun M, Yao W, Wang F, Li X, Wang W, et al. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. J Immunother Cancer. 2020;8(1). https:\/\/doi.org\/10.1136\/jitc-2019-000317.","DOI":"10.1136\/jitc-2019-000317"},{"key":"4890_CR9","doi-asserted-by":"publisher","unstructured":"Boutilier AJ, Elsawa SF. Macrophage Polarization States in the Tumor Microenvironment. Int J Mol Sci. 2021;22(13). https:\/\/doi.org\/10.3390\/ijms22136995.","DOI":"10.3390\/ijms22136995"},{"key":"4890_CR10","doi-asserted-by":"publisher","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lou Y, Wang J, Yu C, Shen W. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment. Front Immunol. 2020;11:609705. https:\/\/doi.org\/10.3389\/fimmu.2020.609705.","journal-title":"Front Immunol"},{"key":"4890_CR11","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang Q, Chen Y, Liang CL, Liu H, Qiu F, et al. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother Biomedecine & pharmacotherapie. 2020;121:109570. https:\/\/doi.org\/10.1016\/j.biopha.2019.109570.","DOI":"10.1016\/j.biopha.2019.109570"},{"key":"4890_CR12","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:105728. https:\/\/doi.org\/10.1016\/j.phrs.2021.105728.","journal-title":"Pharmacol Res"},{"issue":"3","key":"4890_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ptr.7390","volume":"36","author":"M Samadi","year":"2022","unstructured":"Samadi M, Moradinazar M, Khosravy T, Soleimani D, Jahangiri P, Kamari N. A systematic review and meta-analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease. Phytotherapy research\u202f: PTR. 2022;36(3):1182\u201393. https:\/\/doi.org\/10.1002\/ptr.7390.","journal-title":"Phytotherapy research : PTR"},{"issue":"4","key":"4890_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jcmgh.2021.06.007","volume":"12","author":"J Ahn","year":"2021","unstructured":"Ahn J, Lee H, Jung CH, Ha SY, Seo HD, Kim YI, et al. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4\u03b1\/miR-467b-3p\/GPAT1 Cascade. Cell Mol Gastroenterol Hepatol. 2021;12(4):1201\u201313. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.06.007.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4890_CR15","doi-asserted-by":"publisher","unstructured":"Liu Y, Li D, Wang S, Peng Z, Tan Q, He Q, et al. 6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1\/AMPK Signaling. Int J Mol Sci. 2023;24(7). https:\/\/doi.org\/10.3390\/ijms24076285.","DOI":"10.3390\/ijms24076285"},{"key":"4890_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.taap.2018.11.001","volume":"362","author":"J Li","year":"2019","unstructured":"Li J, Wang S, Yao L, Ma P, Chen Z, Han TL, et al. 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2019;362:125\u201335. https:\/\/doi.org\/10.1016\/j.taap.2018.11.001.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Pt A","key":"4890_CR17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ijbiomac.2022.11.104","volume":"223","author":"JP Liu","year":"2022","unstructured":"Liu JP, Wang J, Zhou SX, Huang DC, Qi GH, Chen GT. Ginger polysaccharides enhance intestinal immunity by modulating gut microbiota in cyclophosphamide-induced immunosuppressed mice. Int J Biol Macromol. 2022;223(Pt A):1308\u201319. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.104.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"4890_CR18","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1002\/ptr.7784","volume":"37","author":"C Song","year":"2023","unstructured":"Song C, Ji Y, Wang W, Tao N. Ginger polysaccharide promotes myeloid-derived suppressor cell apoptosis by regulating lipid metabolism. Phytotherapy research\u202f: PTR. 2023;37(7):2894\u2013901. https:\/\/doi.org\/10.1002\/ptr.7784.","journal-title":"Phytotherapy research : PTR"},{"key":"4890_CR19","doi-asserted-by":"publisher","unstructured":"Hamza AA, Heeba GH, Hamza S, Abdalla A, Amin A. Standardized extract of ginger ameliorates liver cancer by reducing proliferation and inducing apoptosis through inhibition oxidative stress\/ inflammation pathway. Biomed Pharmacother. 2021;134:111102. https:\/\/doi.org\/10.1016\/j.biopha.2020.111102.","DOI":"10.1016\/j.biopha.2020.111102"},{"key":"4890_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biomaterials.2016.06.018","volume":"101","author":"M Zhang","year":"2016","unstructured":"Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321\u201340. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.018.","journal-title":"Biomaterials"},{"key":"4890_CR21","doi-asserted-by":"publisher","unstructured":"Chen CY, Chen YN, Shiau JP, Tang JY, Hou MF, Chang HW. Ginger-Derived 3HDT Exerts Antiproliferative Effects on Breast Cancer Cells by Apoptosis and DNA Damage. Int J Mol Sci. 2023;24(6). https:\/\/doi.org\/10.3390\/ijms24065741.","DOI":"10.3390\/ijms24065741"},{"issue":"4","key":"4890_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","volume":"75","author":"R Pinyol","year":"2021","unstructured":"Pinyol R, Torrecilla S, Wang H, Montironi C, Piqu\u00e9-Gili M, Torres-Martin M, et al. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2021;75(4):865\u201378. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.049.","journal-title":"J Hepatol"},{"issue":"8","key":"4890_CR23","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/ijc.30219","volume":"139","author":"G Xie","year":"2016","unstructured":"Xie G, Wang X, Huang F, Zhao A, Chen W, Yan J, et al. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int J Cancer. 2016;139(8):1764\u201375. https:\/\/doi.org\/10.1002\/ijc.30219.","journal-title":"Int J Cancer"},{"key":"4890_CR24","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.2147\/dddt.S178217","volume":"12","author":"S Qi","year":"2018","unstructured":"Qi S, Feng Z, Li Q, Qi Z, Zhang Y. Inhibition of ROS-mediated activation Src-MAPK\/AKT signaling by orientin alleviates H(2)O(2)-induced apoptosis in PC12 cells. Drug Des Dev Ther. 2018;12:3973\u201384. https:\/\/doi.org\/10.2147\/dddt.S178217.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"4890_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41392-020-0193-z","volume":"5","author":"J Chen","year":"2020","unstructured":"Chen J, Wang Y, Zhang W, Zhao D, Zhang L, Fan J, et al. Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cells. Signal Transduct Target Ther. 2020;5(1):139. https:\/\/doi.org\/10.1038\/s41392-020-0193-z.","journal-title":"Signal Transduct Target Ther"},{"key":"4890_CR26","doi-asserted-by":"publisher","first-page":"154638","DOI":"10.1016\/j.phymed.2022.154638","volume":"110","author":"Q Kong","year":"2023","unstructured":"Kong Q, Ma M, Zhang L, Liu S, He S, Wu J, et al. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC\/ERK\/STAT3 signaling pathways. Phytomedicine\u202f: Int J Phytother Phytopharmacol. 2023;110:154638. https:\/\/doi.org\/10.1016\/j.phymed.2022.154638.","journal-title":"Phytomedicine : Int J Phytother Phytopharmacol"},{"issue":"11","key":"4890_CR27","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1111\/jcmm.15288","volume":"24","author":"HM Luo","year":"2020","unstructured":"Luo HM, Wu X, Xian X, Wang LY, Zhu LY, Sun HY, et al. Calcitonin gene-related peptide inhibits angiotensin II-induced NADPH oxidase-dependent ROS via the Src\/STAT3 signalling pathway. J Cell Mol Med. 2020;24(11):6426\u201337. https:\/\/doi.org\/10.1111\/jcmm.15288.","journal-title":"J Cell Mol Med"},{"key":"4890_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.redox.2015.07.005","volume":"6","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist E, Fabregat I. Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biol. 2015;6:106\u201311. https:\/\/doi.org\/10.1016\/j.redox.2015.07.005.","journal-title":"Redox Biol"},{"issue":"8","key":"4890_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","volume":"67","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, et al. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut. 2018;67(8):1493\u2013504. https:\/\/doi.org\/10.1136\/gutjnl-2017-315193.","journal-title":"Gut"},{"issue":"4","key":"4890_CR30","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.jhepr.2021.100305","volume":"3","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Henry L. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP reports\u202f: Innov Hepatol. 2021;3(4):100305. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100305.","journal-title":"JHEP reports : Innov Hepatol"},{"issue":"5","key":"4890_CR31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023;164(5):766\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033.","journal-title":"Gastroenterology"},{"issue":"1","key":"4890_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cgh.2023.05.019","volume":"22","author":"JH Koh","year":"2024","unstructured":"Koh JH, Ng CH, Nah B, Tan DJH, Loomba R, Huang DQ. NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2024;22(1):197-9.e3. https:\/\/doi.org\/10.1016\/j.cgh.2023.05.019.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"4890_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","volume":"20","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenw\u00e4lder M, El-Serag HB, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20(8):487\u2013503. https:\/\/doi.org\/10.1038\/s41575-023-00754-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4890_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283\u201398. https:\/\/doi.org\/10.5582\/bst.2021.01318.","journal-title":"Biosci Trends"},{"key":"4890_CR35","doi-asserted-by":"publisher","first-page":"829101","DOI":"10.3389\/fnut.2022.829101","volume":"9","author":"IA Al-Ataby","year":"2022","unstructured":"Al-Ataby IA, Talib WH. Daily Consumption of Lemon and Ginger Herbal Infusion Caused Tumor Regression and Activation of the Immune System in a Mouse Model of Breast Cancer. Front Nutr. 2022;9:829101. https:\/\/doi.org\/10.3389\/fnut.2022.829101.","journal-title":"Front Nutr"},{"key":"4890_CR36","doi-asserted-by":"publisher","first-page":"129261","DOI":"10.1016\/j.foodchem.2021.129261","volume":"350","author":"X Yang","year":"2021","unstructured":"Yang X, Wei S, Lu X, Qiao X, Simal-Gandara J, Capanoglu E, et al. A neutral polysaccharide with a triple helix structure from ginger: Characterization and immunomodulatory activity. Food Chem. 2021;350:129261. https:\/\/doi.org\/10.1016\/j.foodchem.2021.129261.","journal-title":"Food Chem"},{"issue":"18","key":"4890_CR37","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.Can-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Can Res. 2019;79(18):4557\u201366. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-3962.","journal-title":"Can Res"},{"issue":"1","key":"4890_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98. https:\/\/doi.org\/10.1186\/s13045-021-01103-4.","journal-title":"J Hematol Oncol"},{"key":"4890_CR39","doi-asserted-by":"publisher","unstructured":"Li C, Xu X, Wei S, Jiang P, Xue L, Wang J. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer. 2021;9(1). https:\/\/doi.org\/10.1136\/jitc-2020-001341.","DOI":"10.1136\/jitc-2020-001341"},{"key":"4890_CR40","doi-asserted-by":"publisher","first-page":"121137","DOI":"10.1016\/j.biomaterials.2021.121137","volume":"278","author":"GR Gunassekaran","year":"2021","unstructured":"Gunassekaran GR, Poongkavithai Vadevoo SM, Baek MC, Lee B. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Biomaterials. 2021;278:121137. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121137.","journal-title":"Biomaterials"},{"issue":"1","key":"4890_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","volume":"40","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/\u03b2-catenin\/c-Myc signaling and reprogramming glycolysis. J Experiment Clin Cancer Res. 2021;40(1):13. https:\/\/doi.org\/10.1186\/s13046-020-01808-3.","journal-title":"J Experiment Clin Cancer Res"},{"key":"4890_CR42","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.redox.2022.102452","volume":"56","author":"J Liu","year":"2022","unstructured":"Liu J, Wei Y, Jia W, Can C, Wang R, Yang X, et al. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization. Redox Biol. 2022;56:102452. https:\/\/doi.org\/10.1016\/j.redox.2022.102452.","journal-title":"Redox Biol"},{"issue":"20","key":"4890_CR43","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer. Theranostics. 2020;10(20):9332\u201347. https:\/\/doi.org\/10.7150\/thno.47137.","journal-title":"Theranostics"},{"issue":"12","key":"4890_CR44","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1007\/s00262-023-03547-8","volume":"72","author":"X Hu","year":"2023","unstructured":"Hu X, Ding S, Lu G, Lin Z, Liao L, Xiao W, et al. Apolipoprotein C-III itself stimulates the Syk\/cPLA2-induced inflammasome activation of macrophage to boost anti-tumor activity of CD8(+) T cell. Cancer Immunol Immunother. 2023;72(12):4123\u201344. https:\/\/doi.org\/10.1007\/s00262-023-03547-8.","journal-title":"Cancer Immunol Immunother"},{"key":"4890_CR45","doi-asserted-by":"publisher","unstructured":"P\u00e9rez S, Rius-P\u00e9rez S. Macrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective. Antioxidants (Basel, Switzerland). 2022;11(7). https:\/\/doi.org\/10.3390\/antiox11071394.","DOI":"10.3390\/antiox11071394"},{"issue":"1","key":"4890_CR46","doi-asserted-by":"publisher","first-page":"13582","DOI":"10.1038\/s41598-020-70137-4","volume":"10","author":"DJ Shiau","year":"2020","unstructured":"Shiau DJ, Kuo WT, Davuluri GVN, Shieh CC, Tsai PJ, Chen CC, et al. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2\/NOX2\/autophagy axis. Sci Rep. 2020;10(1):13582. https:\/\/doi.org\/10.1038\/s41598-020-70137-4.","journal-title":"Sci Rep"},{"issue":"6","key":"4890_CR47","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.7150\/thno.92672","volume":"14","author":"SMP Vadevoo","year":"2024","unstructured":"Vadevoo SMP, Kang Y, Gunassekaran GR, Lee SM, Park MS, Jo DG, et al. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis. Theranostics. 2024;14(6):2605\u201321. https:\/\/doi.org\/10.7150\/thno.92672.","journal-title":"Theranostics"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04890-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:30:22Z","timestamp":1745422222000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04890-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04890-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}